All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

detroit

columbus

austin

kansas-city

dallas

atlanta

washington-dc

nw-arkansas

boulder

chicago

indianapolis

nashville

richmond

houston

san-francisco

seattle

colorado-springs

boston

des-moines

salt-lake-city

philadelphia

denver

phoenix

new-orleans

miami

twin-cities

huntsville

raleigh

san-antonio

portland

san-diego

tampa-bay

cleveland

pittsburgh

axios-local

axios-pro

axios-live

the-axios-show

Advent International is paying more than $1.4 billion for health ad agency PatientPoint, Axios has learned.

Why it matters: It's the third health tech comms deal this summer.

Zoom in: Advent acquired the company for more than 12x its $120 million EBITDA, a source familiar tells Axios.

The big picture: Sponsors remain competitive bidders for companies that help pharma commercialize drugs, despite a federal threat to curb direct-to-consumer marketing.

Catch up quick: The deal was originally announced Monday without pricing, following a Jefferies and Citi-led auction that launched earlier this summer. 

Advent will acquire the stakes of existing investors L Catterton (since 2007), Littlejohn and Transformation Capital (since 2021). 

Flashback: PatientPoint merged with peer Outcome Health four years ago in a deal that valued the combined entity at north of $1 billion.

How it works: PatientPoint sells educational content and ads in physicians' offices, exam rooms and waiting rooms — giving pharmaceutical companies access to patients at the point of care.

State of play: Deals for health comms plays keep flowing.

Publicis Health agreed to acquire life sciences comms firm P-value Group for between $250 million and $300 million, Axios Pro reported earlier this month.

In July, GTCR sold its stake in Klick Health to GIC and Linden Capital in the deal valuing the company at $2.5 billion, or 18x EBITDA. 

Also, Amulet Capital is exploring a sale of biotech consultant SSI Strategy, Axios Pro reported in June. 

Advent declined to comment. L Catterton, Littlejohn, Transformation Capital, and PatientPoint did not respond to a request for comment. 

Scoop: Advent paying $1.4B-plus for PatientPoint

Sponsors remain competitive for plays that help pharma commercialize drugs.

Illustration of text boxes in the shape of a hundred dollar bill and a pill clashing

Advent International is paying more than $1.4 billion for health ad agency <a class="gtmContentClick" data-vars-link-text="PatientPoint" data-vars-click-url="https://www.axios.com/pro/health-tech-deals/2025/06/04/patientpoint-jefferies-sale" data-vars-content-id="b3bce43a-df1b-489a-9494-b7dcecd78d31" data-vars-headline="Scoop: Advent paying $1.4B-plus for PatientPoint" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/pro/health-tech-deals/2025/06/04/patientpoint-jefferies-sale" target="_self">PatientPoint</a>, Axios has learned.Why it matters: It&#x27;s the third health tech comms deal this summer.

Scoop: Advent paying $1.4B-plus for PatientPoint

What to read next